Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Dec;18(12):1919-27.
doi: 10.1517/13543780903376163.

Polidocanol for endovenous microfoam sclerosant therapy

Affiliations
Review

Polidocanol for endovenous microfoam sclerosant therapy

David M Eckmann. Expert Opin Investig Drugs. 2009 Dec.

Abstract

Background: Polidocanol is a liquid surfactant having endothelial cell lytic properties. In the form of a controlled, dispensed microfoam it is administered endovenously as a sclerosing agent in the treatment of varicose veins.

Objective: This review summarizes efficacy of polidocanol endovenous microfoam sclerotherapy using a proprietary dispensing system to control foam characteristics and gas content for treating varicose veins.

Methods: We reviewed in vitro, Phase I, Phase II and limited Phase III data for polidocanol microfoam with a focus on controlled foam formulation in therapy.

Results/conclusions: Clinical trials of controlled dispensing of polidocanol microfoam provide evidence of effective treatment of chronic venous insufficiency with low toxicity, minimal risk and few complications.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest

The author has no conflict of interest to declare and no fee has been received for preparation of the manuscript.

Figures

Figure 1
Figure 1
Chemical structure of polidocanol.
Figure 2
Figure 2
The Varisolve® polidocanol endovenous microfoam generation and dispensing canister.

Similar articles

Cited by

References

    1. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005;15:175–84. - PubMed
    1. Criqui MH, Jamosmos M, Fronek A, et al. Chronic venous disease in an ethnically diverse population: the San Diego population study. Am J Epidemiol. 2003;158:448–56. - PMC - PubMed
    1. Kundu S, Lurie F, Millward SF, et al. Recommended reporting standards for endovenous ablation for the treatment of venous insufficiency: joint statement of The American Venous Forum and The Society of Interventional Radiology. J Vasc Surg. 2007;46:582–9. - PubMed
    1. Mozes G, Kalra M, Carmo M, et al. Extension of saphenous thrombus into the femoral vein: a potential complication of new endovenous ablation techniques. J Vasc Surg. 2005;41:130–5. - PubMed
    1. Wollmann JC. The history of sclerosing foams. Dermatol Surg. 2004;30:694–703. - PubMed

Publication types

MeSH terms

LinkOut - more resources